![Ginny Blocki](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ginny Blocki
Vendite & Marketing presso EMBECTA CORP.
Posizioni attive di Ginny Blocki
Società | Posizione | Inizio | Fine |
---|---|---|---|
EMBECTA CORP. | Vendite & Marketing | 22/03/2022 | - |
Storia della carriera di Ginny Blocki
Precedenti posizioni note di Ginny Blocki
Società | Posizione | Inizio | Fine |
---|---|---|---|
BECTON, DICKINSON AND COMPANY | Vendite & Marketing | 01/10/2021 | 01/03/2022 |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/06/2020 | 01/10/2021 |
BAXALTA INC | Vendite & Marketing | - | - |
ABBOTT LABORATORIES | Vendite & Marketing | - | - |
Assertio Therapeutics, Inc.
![]() Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Corporate Officer/Principal | - | - |
Formazione di Ginny Blocki
Indiana University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Posizioni
Sales & Marketing | 4 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Settori
Health Technology | 7 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
EMBECTA CORP. | Health Technology |
BECTON, DICKINSON AND COMPANY | Health Technology |
BAXTER INTERNATIONAL INC. | Health Technology |
ABBOTT LABORATORIES | Health Technology |
Aziende private | 2 |
---|---|
Assertio Therapeutics, Inc.
![]() Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Baxalta, Inc.
![]() Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
- Borsa valori
- Insiders
- Ginny Blocki
- Esperienza